Cullen Investment Group LTD. Sells 10,150 Shares of UnitedHealth Group Incorporated $UNH

Cullen Investment Group LTD. lessened its stake in UnitedHealth Group Incorporated (NYSE:UNH) by 55.6% in the 4th quarter, according to its most recent disclosure with the Securities & Exchange Commission. The firm owned 8,092 shares of the healthcare conglomerate’s stock after selling 10,150 shares during the quarter. Cullen Investment Group LTD.’s holdings in UnitedHealth Group were worth $2,784,000 at the end of the most recent reporting period.

Other institutional investors have also added to or reduced their stakes in the company. Beacon Financial Strategies CORP bought a new position in UnitedHealth Group during the 4th quarter worth about $26,000. Foster Dykema Cabot & Partners LLC grew its holdings in shares of UnitedHealth Group by 69.4% during the third quarter. Foster Dykema Cabot & Partners LLC now owns 83 shares of the healthcare conglomerate’s stock worth $29,000 after buying an additional 34 shares in the last quarter. 1248 Management LLC bought a new stake in UnitedHealth Group in the 3rd quarter valued at approximately $29,000. Holos Integrated Wealth LLC bought a new position in shares of UnitedHealth Group during the 4th quarter worth approximately $29,000. Finally, Hurley Capital LLC raised its holdings in shares of UnitedHealth Group by 81.6% in the third quarter. Hurley Capital LLC now owns 89 shares of the healthcare conglomerate’s stock valued at $31,000 after purchasing an additional 40 shares during the last quarter. 87.86% of the stock is owned by institutional investors.

Key Stories Impacting UnitedHealth Group

Here are the key news stories impacting UnitedHealth Group this week:

• Positive Sentiment: UNH is expanding AI investments to drive efficiency and margin improvement; management reiterated growth and operational-improvement priorities at conferences, which supports medium-term profitability. UnitedHealth (UNH) Expands AI Investments to Boost Efficiency
• Positive Sentiment: Recent quarterly results showed a small EPS beat and revenue growth year-over-year; that underlying earnings strength and management’s reiterated guidance provide a constructive earnings foundation (supports analyst valuation).
• Neutral Sentiment: Wall Street analysts remain broadly bullish on UNH (average brokerage recommendation favors buying), which can prop up the stock, though the coverage is noted as often optimistic and may have limited immediate impact. Is It Worth Investing in UnitedHealth (UNH) Based on Wall Street’s Bullish Views?
• Neutral Sentiment: Industry hiring and AI-focused vendor moves (e.g., executive hiring at an AI-driven claims remediation firm) highlight sector innovation trends that could indirectly benefit large payor/Optum capabilities, but impact on UNH’s near-term stock trajectory is unclear. Andrew Harris Joins Red Sky Health as Senior Vice President of Operations
• Negative Sentiment: The DOJ has intensified an antitrust probe into Optum and UnitedHealth’s integrated model; heightened regulatory scrutiny raises headline risk, potential remedies, and valuation uncertainty for UNH. DOJ Antitrust Probe Puts Focus On UnitedHealth Valuation And Integrated Model
• Negative Sentiment: A proposed settlement in an insulin pricing case would leave CVS Caremark settled while UnitedHealth remains the sole holdout, underscoring litigation and competitive risks that could lead to future costs or reputational impacts if UNH becomes a target. CVS, FTC reach proposed settlement in insulin pricing case

UnitedHealth Group Price Performance

Shares of NYSE UNH opened at $270.48 on Thursday. UnitedHealth Group Incorporated has a twelve month low of $234.60 and a twelve month high of $606.36. The company has a market cap of $245.51 billion, a PE ratio of 20.51, a price-to-earnings-growth ratio of 1.25 and a beta of 0.41. The business’s 50 day moving average price is $293.25 and its two-hundred day moving average price is $323.43. The company has a quick ratio of 0.79, a current ratio of 0.79 and a debt-to-equity ratio of 0.72.

UnitedHealth Group (NYSE:UNH) last posted its earnings results on Tuesday, January 27th. The healthcare conglomerate reported $2.11 earnings per share for the quarter, topping analysts’ consensus estimates of $2.09 by $0.02. UnitedHealth Group had a return on equity of 14.79% and a net margin of 2.69%.The business had revenue of $113.73 billion for the quarter, compared to analyst estimates of $113.38 billion. During the same period in the previous year, the firm earned $6.81 EPS. The firm’s revenue was up 12.3% compared to the same quarter last year. UnitedHealth Group has set its FY 2026 guidance at 17.750- EPS. On average, analysts predict that UnitedHealth Group Incorporated will post 29.54 EPS for the current year.

UnitedHealth Group Dividend Announcement

The business also recently announced a quarterly dividend, which was paid on Tuesday, March 17th. Investors of record on Monday, March 9th were issued a dividend of $2.21 per share. The ex-dividend date of this dividend was Monday, March 9th. This represents a $8.84 annualized dividend and a dividend yield of 3.3%. UnitedHealth Group’s payout ratio is presently 67.02%.

Analysts Set New Price Targets

UNH has been the subject of a number of analyst reports. Royal Bank Of Canada decreased their target price on shares of UnitedHealth Group from $408.00 to $361.00 and set an “outperform” rating for the company in a research report on Wednesday, January 28th. KeyCorp restated an “overweight” rating on shares of UnitedHealth Group in a report on Wednesday, January 28th. Mizuho dropped their target price on UnitedHealth Group from $430.00 to $350.00 and set an “outperform” rating on the stock in a report on Thursday, February 5th. JPMorgan Chase & Co. lowered their price target on UnitedHealth Group from $425.00 to $389.00 and set an “overweight” rating on the stock in a research report on Monday, February 2nd. Finally, Jefferies Financial Group cut their price objective on UnitedHealth Group from $418.00 to $340.00 and set a “buy” rating for the company in a report on Wednesday, January 28th. One research analyst has rated the stock with a Strong Buy rating, seventeen have assigned a Buy rating, eight have issued a Hold rating and two have issued a Sell rating to the company. Based on data from MarketBeat.com, UnitedHealth Group has a consensus rating of “Moderate Buy” and an average price target of $372.13.

UnitedHealth Group Company Profile

UnitedHealth Group Inc is a diversified health care company headquartered in Minnetonka, Minnesota, that operates two primary business platforms: UnitedHealthcare and Optum. Founded in 1977, the company provides a broad range of health benefits and health care services to individuals, employers, governmental entities and other organizations. Its operations span commercial employer-sponsored plans, individual and Medicare and Medicaid programs, and services for customers and health systems in the United States and selected international markets.

UnitedHealthcare is the company’s benefits business, administering health plans and networks, managing provider relationships, and offering coverage products for employers, individuals, and government-sponsored programs.